NCAPG and ovarian carcinoma: Studies have shown (28) that interference with NCAPG can inhibit the growth, proliferation and invasion of ovarian cancer cells (OC) by promoting the activation of the p38 MAPK signaling pathway, and it blocks the cell cycle and promotes apoptosis in the G2 and S phases.